Literature DB >> 9795827

Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders.

F Cruz1.   

Abstract

Recent experimental studies have identified a category of unmyelinated type C bladder afferent fibers in the pelvic nerves which are extremely sensitive to capsaicin. Sensory input conveyed by these fibers triggers a spinal reflex which, in chronic spinalized animals, facilitates and controls micturition. In addition, bladder C fibers were also shown to have a role in bladder pain perception. In humans capsaicin-sensitive afferent fibers also innervate the bladder and contribute to the reflexogenic control of the detrusor muscle and to bladder pain perception. Desensitization of such fibers by intravesical administration of capsaicin, presumably by blocking sensory transmission, has been shown to reduce involuntary micturition and to increase bladder capacity in patients with detrusor hyperreflexia of spinal origin, and to reduce the intensity of bladder pain in patients with bladder hypersensitivity. Very recently, resiniferatoxin, an ultrapotent capsaicin analog, was shown to have a similar clinical effect in this subset of patients. However, unlike capsaicin, resiniferatoxin did not evoke acute irritative urinary symptoms during bladder instillation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795827     DOI: 10.1007/bf01901607

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  39 in total

1.  Intravesical capsaicin for neurogenic bladder dysfunction.

Authors:  C J Fowler; D Jewkes; W I McDonald; B Lynn; W C de Groat
Journal:  Lancet       Date:  1992-05-16       Impact factor: 79.321

2.  A bladder-to-bladder cooling reflex in the cat.

Authors:  M Fall; S Lindström; L Mazières
Journal:  J Physiol       Date:  1990-08       Impact factor: 5.182

Review 3.  The overactive bladder: pharmacologic basis of drug treatment.

Authors:  K E Andersson
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

4.  The consequences of long-term topical capsaicin application in the rat.

Authors:  Stephen B McMahon; Gary Lewin; Stephen R Bloom
Journal:  Pain       Date:  1991-03       Impact factor: 6.961

5.  Urodynamic changes during therapeutic intravesical instillations of capsaicin.

Authors:  V A Chandiramani; T Peterson; G S Duthie; C J Fowler
Journal:  Br J Urol       Date:  1996-06

6.  Intravesical capsaicin in neurologic impaired patients with detrusor hyperreflexia.

Authors:  A Das; M B Chancellor; T Watanabe; J Sedor; D A Rivas
Journal:  J Spinal Cord Med       Date:  1996-07       Impact factor: 1.985

7.  Effect of chronic atropine administration on the rat urinary bladder.

Authors:  R M Levin; M R Ruggieri; W Lee; A J Wein
Journal:  J Urol       Date:  1988-06       Impact factor: 7.450

8.  The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin.

Authors:  C S Walpole; S Bevan; G Bovermann; J J Boelsterli; R Breckenridge; J W Davies; G A Hughes; I James; L Oberer; J Winter
Journal:  J Med Chem       Date:  1994-06-24       Impact factor: 7.446

9.  Intravesical capsaicin for treatment of detrusor hyperreflexia.

Authors:  C J Fowler; R O Beck; S Gerrard; C D Betts; C G Fowler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

10.  Lidocaine prevents noxious excitation of bladder afferents induced by intravesical capsaicin without interfering with the ensuing sensory desensitization: an experimental study in the rat.

Authors:  A Avelino; F Cruz; A Coimbra
Journal:  J Urol       Date:  1998-02       Impact factor: 7.450

View more
  9 in total

Review 1.  From urgency to frequency: facts and controversies of TRPs in the lower urinary tract.

Authors:  Roman Skryma; Natalia Prevarskaya; Dimitra Gkika; Yaroslav Shuba
Journal:  Nat Rev Urol       Date:  2011-10-04       Impact factor: 14.432

2.  Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC).

Authors:  Tony Y H Chen; Jacques Corcos; Michel Camel; Yves Ponsot; Le Mai Tu
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-04-08

Review 3.  Potential therapeutic value of transient receptor potential channels in male urogenital system.

Authors:  Gamze Toktanis; Ecem Kaya-Sezginer; Didem Yilmaz-Oral; Serap Gur
Journal:  Pflugers Arch       Date:  2018-09-07       Impact factor: 3.657

Review 4.  TRP channels in lower urinary tract dysfunction.

Authors:  J Franken; P Uvin; D De Ridder; T Voets
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 5.  Capsaicin treatment of idiopathic rhinitis: the new panacea?

Authors:  Jeroen B van Rijswijk; Roy Gerth van Wijk
Journal:  Curr Allergy Asthma Rep       Date:  2006-03       Impact factor: 4.806

Review 6.  Vanilloid receptor ligands: hopes and realities for the future.

Authors:  A Szallasi
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

7.  Capsaicin and menthol in the treatment of itch and pain: recently cloned receptors provide the key.

Authors:  P Anand
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

Review 8.  Role of neurogenic inflammation in local communication in the visceral mucosa.

Authors:  Lori A Birder; F Aura Kullmann
Journal:  Semin Immunopathol       Date:  2018-03-26       Impact factor: 9.623

9.  Effects of Dietary Vitamin E Supplementation in Bladder Function and Spasticity during Spinal Cord Injury.

Authors:  Kathia Cordero; Gemma G Coronel; Miguel Serrano-Illán; Jennifer Cruz-Bracero; Johnny D Figueroa; Marino De León
Journal:  Brain Sci       Date:  2018-02-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.